JMP Securities Maintains Market Outperform on Ultragenyx Pharmaceutical, Lowers Price Target to $80

JMP Securities maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Market Outperform and lowers the price target from $82 to $80.

Benzinga · 11/06/2019 14:01

JMP Securities maintains Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Market Outperform and lowers the price target from $82 to $80.